WORLDSymposium 2020 Young Investigator Awards
WORLDSymposium was pleased to announce the 11 recipients of the 2020 Young Investigator Awards on Monday, February 10, 2020. Click to view award recipients.
WORLDSymposium was pleased to announce the 11 recipients of the 2020 Young Investigator Awards on Monday, February 10, 2020. Click to view award recipients.
WORLDSymposium 2020 attracted over 40 Exhibitors offering a highly interactive forum for discussion of lysosomal diseases with international researchers and health care practitioners View Exhibitor and Patient Advocate list.
15 Satellite symposia were held from Tuesday, February 11, 2020 to Thursday, February 13, 2020. Click here for the full schedule.
For the eigth consecutive year, WORLDSymposium began with Emerging Trends in Lysosomal Biology & Lysosomal Diseases: State-of-the-art for Experts on Monday, February 10, 2022. See agenda and faculty.
In 2020, over 480 scientific abstracts were presented at three separate poster sessions beginning on Monday, February 10 2020, and remained open throughout the rest of the conference. View Poster List.
Following Emerging Trends in the morning and the Young Investigator Awards, presentations in the afternoon session discussed innovations in technology and how they can be applied to early diagnosis for lysosomal conditions, progress in gene therapy, and exploitation of differences at the cellular level that may indicate early disease state. View full program.
WORLDSymposium 2020 Roscoe O. Brady Award was received by John F. Crowley, MD for Innovation and Accomplishment on Tuesday, February 11, 2020. John F. Crowley is the Chairman and CEO of Amicus Therapeutics, a global biotechnology company focusing on developing treatments for rare genetic diseases. More details.
WORLDSymposium 2020 Patient Advocate Leader (PAL) Award was received by Cara O’Neill, MD on Wednesday, February 12, 2020. Cara O’Neill, MD, is the Chief Science Officer at Cure Sanfilippo Foundation, a pediatrician, and mother to a daughter with the rare disease Sanfilippo syndrome (MPS III). More details.
Chester B. Whitley, PhD, MD delivered the keynote address on Wednesday, February 12, 2020 and Peter Marks, MD, PhD delivered the keynote address on Thursday, February 13, 2020. Dr. Whitley is the Principal Investigator for the Lysosomal Disease Network (LDN), a growing consortium of medical centers collaborating since 2003 and is the director of the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA). Read speaker bios.